| NCT ID | NCT03461237 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beijing Jishuitan Hospital |
| Condition | Hip Fractures |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2017-05-01 |
| Primary Completion | 2026-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2017-05-01 with a primary completion date of 2026-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
1. To Compare overall rates of second hip fractures in both genders, 2. To determine the effect of hip fracture on proximal femoral volumetric bone mineral density (vBMD), bone structure and muscle by quantitative computed tomography(QCT), 3. To evaluate the contribution of QCT-image analysis to the prediction of the second hip fracture risk. 4. To identify the differences between femoral neck fracture and trochanter fracture following hip fracture
Eligibility Criteria
Inclusion Criteria: * a:Osteoporotic patients b:Osteoporotic hip fracture patients (femoral neck fracture and femoral trochanteric fracture) c: Be willing to and be able to join in the study and sighed the informed consent Exclusion Criteria: * a:Under 47years old b:Non-surgical repair of hip fracture c:Pathologic fracture d:Violence-related trauma e:Bilateral hip implants or have hip replacement on the non-fractured side
Contact & Investigator
Xiaoguang Cheng, MD
PRINCIPAL INVESTIGATOR
department of radiology, Beijing Jishuitan Hospital
Frequently Asked Questions
Who can join the NCT03461237 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 95 Years, studying Hip Fractures. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03461237 currently recruiting?
Yes, NCT03461237 is actively recruiting participants. Contact the research team at xiao65@263.net for enrollment information.
Where is the NCT03461237 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT03461237 clinical trial?
NCT03461237 is sponsored by Beijing Jishuitan Hospital. The principal investigator is Xiaoguang Cheng, MD at department of radiology, Beijing Jishuitan Hospital. The trial plans to enroll 3,000 participants.